Skip to content
FDA approves first monoclonal antibody to treat COVID-19
The U.S. Food and Drug Administration (FDA) approved Genentech’s Actemra to treat COVID-19 ...
Read More
What’s happening with the COVID IP waiver expansion?
The United States and the Biotechnology Innovation Organization (BIO) have been taking action ...
Read More
Senate confirms Alexis Taylor as USDA trade undersecretary
The Senate on Wednesday confirmed Alexis Taylor to become the U.S. Department of ...
Read More
What’s in the government’s omnibus spending package
The text of the 4,155-page, $1.7 trillion omnibus spending bill was delivered around ...
Read More
Teen opioid deaths are on the rise – but OTC Narcan could help
It’s no surprise the COVID-19 pandemic aggravated the United States’ already rampant opioid ...
Read More
Biden Administration seeks public input on how to support biotech
The federal government today released two calls for public input on how the ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
BIO Events
PACE: Downstream effects of IRA on patients
Three years after the passage of the Inflation Reduction Act (IRA), patient advocates and the biotech industry are working to navigate downstream negative impacts on ...
Federal Policy
PACE panel urges incentives for exciting new GTT drugs
Luke Rosen had hoped a new treatment would slow the progression of his daughter’s KIF1A Associated Neurological Disorder (KAND), but was amazed to see an ...
BIO Events
PACE: How 340B outgrew its goal and stopped helping patients
The 340B program, in recent decades, has shown how the best laid plans can go sideways when not kept transparent and properly in check. Initially ...
Federal Policy
BIO CEO John Crowley tells Senate how to support biotech
Maintaining America’s biotechnology leadership requires Food and Drug Administration (FDA) modernization as well as Congressional action to reauthorize a program supporting rare disease research and ...
Health
A legacy of love, leadership, and liberation: Tigerlily’s next chapter
October is Breast Cancer Awareness Month, and to mark the occasion, Bio.News has partnered with the Tigerlily Foundation to explore how they developed their advocacy. ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO PACE 2025: Patients need to ensure state policies enable access to medicine
With Medicaid cuts expected, vaccine hesitancy getting politicized, and the continued challenge of Prescription Drug Affordability Boards (PDABs), state legislatures ...
Read More
International
Bio's View
Putting Americans First: Importing European prices means importing European systems and values
European countries don’t just pull prices for medicines out of thin air. The prices that those governments set are based ...
Read More
